Aeolus Pharmaceuticals Inc (AOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2011 | 09-2010 | 09-2009 | 09-2008 | 09-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 518 | 2,355 | 646 | 399 | 1,727 |
| Receivables | 1,677 | N/A | N/A | N/A | N/A |
| TOTAL | $2,258 | $2,401 | $779 | $555 | $1,806 |
| Non-Current Assets | |||||
| Investments And Advances | 32 | 32 | 32 | 565 | 125 |
| TOTAL | $32 | $32 | $32 | $565 | $125 |
| Total Assets | $2,290 | $2,433 | $811 | $1,120 | $1,931 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 366 | N/A |
| Accounts payable and accrued liabilities | 2,144 | 957 | 774 | 991 | 268 |
| TOTAL | $2,144 | $1,620 | $774 | $1,891 | $268 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 594 | 0 | 483 |
| Other Non-Current Liabilities | 23,405 | 27,549 | 600 | 266 | 0 |
| TOTAL | $23,405 | $27,549 | $1,194 | $266 | $483 |
| Total Liabilities | $25,549 | $29,169 | $1,968 | $2,157 | $751 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 60,471 | 59,684 | 48,224 | 32,031 | 31,953 |
| Common Shares | 605 | 568 | 376 | 320 | 320 |
| Retained earnings | -182,412 | -182,711 | -161,195 | -158,899 | -155,926 |
| Other shareholders' equity | 5 | 5 | 5 | -31 | 5 |
| TOTAL | $-23,259 | $-26,736 | $-1,157 | $-1,037 | $1,180 |
| Total Liabilities And Equity | $2,290 | $2,433 | $811 | $1,120 | $1,931 |